Skip to main content

and
  1. Article

    Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

    Correction to: Bone Marrow Transplantation (2016) 52, 209–215; doi:10.1038/bmt.2016.266; published online 7 November 2016 Since the publication of this article, it has been noted that an acknowledgement was in...

    M Robin, R Porcher, W Zinke-Cerwenka, A van Biezen, L Volin in Bone Marrow Transplantation (2017)

  2. No Access

    Article

    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

    We report a retrospective analysis of 246 myelodysplastic syndrome (MDS) patients in the EBMT (The European Society for Blood and Marrow Transplantation) database who were transplanted for International Progno...

    M Robin, R Porcher, W Zinke-Cerwenka, A van Biezen, L Volin in Bone Marrow Transplantation (2017)

  3. No Access

    Article

    Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation

    T Marchand, T Lamy, H Finel, W Arcese, S Choquet, J Finke, A Huynh, G Irrera in Leukemia (2016)

  4. No Access

    Article

    Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party

    Little is known about the prognostic impact of prior paclitaxel therapy and response to induction chemotherapy defined as the regimen preceding high-dose chemotherapy (HDCT) for the salvage therapy of advanced...

    A Necchi, R Miceli, M Bregni, C Bokemeyer, L A Berger in Bone Marrow Transplantation (2016)

  5. No Access

    Article

    Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

    Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a therapeutic option for adult patients with T-cell ALL (T-ALL). Meanwhile, few allo-SCT data specific to adult T-ALL have been described thus f...

    X Cahu, M Labopin, S Giebel, M Aljurf, S Kyrcz-Krzemien in Bone Marrow Transplantation (2016)

  6. No Access

    Article

    Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party

    The objective of this registry study was to analyse the outcome of patients who underwent allogeneic or autologous haematopoietic stem cell transplantation (HSCT) for hepatosplenic T-cell lymphoma (HSTL), a ra...

    A Tanase, N Schmitz, H Stein, A Boumendil, H Finel, L Castagna, D Blaise in Leukemia (2015)

  7. Article

    Open Access

    Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey

    Current treatment modalities can cure up to 70–80 % of patients with classical Hodgkin lymphoma. Approximately, 20–30 % of patients require further treatment options. Brentuximab vedotin has been approved for ...

    A. Salihoglu, T. Elverdi, I. Karadogan, S. Paydas, E. Ozdemir in Annals of Hematology (2015)

  8. No Access

    Article

    Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT

    A Rovó, M Aljurf, S Chiodi, S Spinelli, N Salooja, G Sucak in Bone Marrow Transplantation (2013)

  9. No Access

    Article

    Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload

    Fungal pulmonary infections (FPIs) are frequent causes of mortality in hematopoietic stem cell transplantation (HSCT) recipients. Determination of the specific risk factors may improve the prognosis. The aim o...

    E Ozyilmaz, M Aydogdu, G Sucak, S Z Aki, Z N Ozkurt in Bone Marrow Transplantation (2010)